A case report of mesalazine alleviating diarrhea in a patient with nasopharyngeal cancer after tislelizumab treatment.
Sign Up to like & getrecommendations! Published in 2025 at "Immunotherapy"
DOI: 10.1080/1750743x.2025.2504323
Abstract: Immunotherapy has become a significant research focus for cancer treatment in recent years because it can generate enduring immunological responses and has promising therapeutic potential. Nevertheless, excessive stimulation of the immune system may adversely affect… read more here.
Keywords: cancer; treatment; mesalazine; patient nasopharyngeal ... See more keywords